Trident Lifeline Board of Directors

Get the latest insights into the leadership at Trident Lifeline. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Hardik Jigishkumar Desai Chairman & Executive Director
Mrs. Rupaben Chetan Jariwala WholeTime Director & CFO
Mr. Shravan Harikrishna Patel Managing Director
Mrs. Maniya Hardik Desai Non Executive Director
Mr. Mishal Shailesh Patel Independent Director
Mrs. Falguni Bhavesh Jariwala Independent Director

Trident Lifeline Share price

TLL

297.05

0.00 (0.00%)
Last updated on 4 Sep, 2025 | 16:00 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

222.00

52 Week High

339.00

The current prices are delayed, login to your account for live prices

Trident Lifeline FAQs

The board at Trident Lifeline consists of experienced professionals, including Mr. Hardik Jigishkumar Desai , Mrs. Rupaben Chetan Jariwala , and others, overseeing the company’s strategic and corporate governance.

Directors at Trident Lifeline are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Hardik Jigishkumar Desai is the current chairman at Trident Lifeline.

Executive directors at Trident Lifeline are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Trident Lifeline adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Trident Lifeline, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.